A Computational Investigation of the Role of Ion Gradients in Signal Generation in Neurons

Author(s):  
Seyed Ali Sadegh Zadeh ◽  
Chandra Kambhampati
ChemPhysChem ◽  
2016 ◽  
Vol 17 (23) ◽  
pp. 3948-3953 ◽  
Author(s):  
Tainah Dorina Marforio ◽  
Andrea Bottoni ◽  
Matteo Calvaresi ◽  
Daniele Fabbri ◽  
Pietro Giacinto ◽  
...  

Chemosensors ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 96
Author(s):  
Gennady Evtugyn ◽  
Anna Porfireva ◽  
Rezeda Shamagsumova ◽  
Tibor Hianik

Carbon nanomaterials offer unique opportunities for the assembling of electrochemical aptasensors due to their high electroconductivity, redox activity, compatibility with biochemical receptors and broad possibilities of functionalization and combination with other auxiliary reagents. In this review, the progress in the development of electrochemical aptasensors based on carbon nanomaterials in 2016–2020 is considered with particular emphasis on the role of carbon materials in aptamer immobilization and signal generation. The synthesis and properties of carbon nanotubes, graphene materials, carbon nitride, carbon black particles and fullerene are described and their implementation in the electrochemical biosensors are summarized. Examples of electrochemical aptasensors are classified in accordance with the content of the surface layer and signal measurement mode. In conclusion, the drawbacks and future prospects of carbon nanomaterials’ application in electrochemical aptasensors are briefly discussed.


2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 6559-6559
Author(s):  
C. Bennett ◽  
B. J. Edwards ◽  
C. C. Tigue ◽  
D. W. Raisch ◽  
D. M. Courtney ◽  
...  

6559 Background: RADAR is the only independent academic pharmacovigilance organization funded exclusively by peer-reviewed grants. We describe the role of high quality case reports in the detection of drug safety signals. Methods: RADAR has identified 11 cancer-related adverse drug reactions (ADRs). Initial reports for small numbers of cases were obtained from our own institution, NU, (4 ADRs) or from referral centers (7 ADRs). Clinicians at these centers voluntarily provided brief case reports to RADAR, who submitted detailed case reports to the FDA/manufacturer. Clinicians were promised that patient/provider data would be kept confidential and that these data would be submitted as peer-reviewed manuscripts. Results: See Table. Conclusions: RADAR was successful at signal generation and amplification because it focused on quality, not quantity of case reports. Pharmacovigilance efforts that allow clinicians to complete brief forms, maintain confidentiality of patient and provider, and result in submission of collaborative manuscripts may improve early detection of drug safety signals initiatives in oncology. [Table: see text] No significant financial relationships to disclose.


2003 ◽  
Vol 159 (3) ◽  
pp. 539-563 ◽  
Author(s):  
Terena L. Holdaway-Clarke ◽  
Peter K. Hepler

2009 ◽  
Vol 141 (1) ◽  
pp. 87-93 ◽  
Author(s):  
Simone Tatoli ◽  
Costantino Zazza ◽  
Nico Sanna ◽  
Amedeo Palma ◽  
Massimiliano Aschi

Sign in / Sign up

Export Citation Format

Share Document